Fig. 2. Proposed decision algorithm for reversal of residual paralysis during emergence taking into account the level of neuromuscular block at that time visually or tactilely estimated with train-of-four (TOF) stimulation at the adductor pollicis (AP) and available reversal agent: (A ) acetylcholinesterase inhibitor combined with an anticholinergic agent or (B ) sugammadex alone. Before TOF ratio (TOFR) estimation, check the neuromuscular monitor (e.g. , electrode positions and polarity, current intensity ≥ 40 mA) and central temperature (e.g. , ≥ 36.5°C). When available and regardless of the therapeutic decision, quantitative assessment of TOFR is recommended. NMBD = nondepolarizing neuromuscular blocking drug; PTC = posttetanic count. * This situation has only been tested with rocuronium.

Fig. 2. Proposed decision algorithm for reversal of residual paralysis during emergence taking into account the level of neuromuscular block at that time visually or tactilely estimated with train-of-four (TOF) stimulation at the adductor pollicis (AP) and available reversal agent: (A ) acetylcholinesterase inhibitor combined with an anticholinergic agent or (B ) sugammadex alone. Before TOF ratio (TOFR) estimation, check the neuromuscular monitor (e.g. , electrode positions and polarity, current intensity ≥ 40 mA) and central temperature (e.g. , ≥ 36.5°C). When available and regardless of the therapeutic decision, quantitative assessment of TOFR is recommended. NMBD = nondepolarizing neuromuscular blocking drug; PTC = posttetanic count. * This situation has only been tested with rocuronium.

Close Modal

or Create an Account

Close Modal
Close Modal